Latest News

HHS proposed viral hepatitis quality measures for Medicaid and health equity implications.

Q2 2024 Watch: Prior authorization rollbacks in Medicaid HCV programs; ADAP and assistance program coverage.

Q1 2024 Watch: Pandemic Medicaid protections ended; millions lost coverage; ADAP and veterans updates.

Q4 2023 Watch: Bipartisan PEPFAR reauthorization push; ADAP coverage and Medicaid updates tracked.

CDC report: HCV persists despite decade-old cure due to payer barriers and screening failures.

Q2 2023 Watch: Braidwood decision impacts PrEP coverage; ADAP coverage analysis and Medicaid program updates.

Q1 2023 Watch: Tennessee rejecting federal HIV funding; updates on ADAPs, Medicaid, veterans care, and harm reduction.

Q4 2022 Watch: HHS renewed opioid emergency; CANN launched monkeypox project; HEPLISAV-B hepatitis B vaccine covered.

Monitoring report documents HCV treatment access challenges across ADAP, Medicaid, and VA systems.

FDA reclassifies HCV testing to reduce regulatory burden and enable new test makers to enter market.

Nobel laureate's HCV vaccine development targeting 2029 offers hope alongside access equity challenges.

WHO 2030 HCV elimination goal at risk; only 5 of 110 countries on track as COVID-19 disrupts progress.

COVID-19 caused a 50% drop in hospital HCV screening and 72% drop in primary care settings.